Kinetic analysis of the interactions between vaccinia virus complement control protein and human complement proteins C3b and C4b

被引:37
作者
Bernet, J [1 ]
Mullick, J [1 ]
Panse, Y [1 ]
Parab, PB [1 ]
Sahu, A [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
基金
英国惠康基金;
关键词
D O I
10.1128/JVI.78.17.9446-9457.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The vaccinia virus complement control protein (VCP) is an immune evasion protein of vaccinia virus. Previously, VCP has been shown to bind and support inactivation of host complement proteins Cab and Cob and to protect the vaccinia virions from antibody-dependent complement-enhanced neutralization. However, the molecular mechanisms involved in the interaction of VCP with its target proteins Cab and Cob have not yet been elucidated. We have utilized surface plasmon resonance technology to study the interaction of VCP with Cab and Cob. We measured the kinetics of binding of the viral protein to its target proteins and compared it with human complement regulators factor H and sCR1, assessed the influence of immobilization of ligand on the binding kinetics, examined the effect of ionic contacts on these interactions, and sublocalized the binding site on Cab and Cob. Our results indicate that (i) the orientation of the ligand is important for accurate determination of the binding constants, as well as the mechanism of binding; (ii) in contrast to factor H and sCR1, the binding of VCP to Cab and Cob follows a simple 1:1 binding model and does not involve multiple-site interactions as predicted earlier; (iii) VCP has a 4.6-fold higher affinity for Cob than that for Cab, which is also reflected in its factor I cofactor activity; (iv) ionic interactions are important for VCP-C3b and VCP-C4b complex formation; (v) VCP does not bind simultaneously to Cab and Cob; and (vi) the binding site of VCP on C3b and C4b is located in the C3dg and C4c regions, respectively.
引用
收藏
页码:9446 / 9457
页数:12
相关论文
共 55 条
[1]   Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen [J].
Ahearn, JM ;
Fischer, MB ;
Croix, D ;
Goerg, S ;
Ma, MH ;
Xia, JR ;
Zhou, XN ;
Howard, RG ;
Rothstein, TL ;
Carroll, MC .
IMMUNITY, 1996, 4 (03) :251-262
[2]   Viral mechanisms of immune evasion [J].
Alcami, A ;
Koszinowski, UH .
TRENDS IN MICROBIOLOGY, 2000, 8 (09) :410-418
[3]   LOCALIZATION OF THE COMPLEMENT-COMPONENT-C3B-BINDING SITE AND THE COFACTOR ACTIVITY FOR FACTOR-I IN THE 38KDA TRYPTIC FRAGMENT OF FACTOR-H [J].
ALSENZ, J ;
LAMBRIS, JD ;
SCHULZ, TF ;
DIERICH, MP .
BIOCHEMICAL JOURNAL, 1984, 224 (02) :389-398
[4]  
[Anonymous], 1998, HUMAN COMPLEMENT SYS
[5]  
ARNAOUT MA, 1983, IMMUNOLOGY, V48, P229
[6]   Viral mimicry of the complement system [J].
Bernet, J ;
Mullick, J ;
Singh, AK ;
Sahu, A .
JOURNAL OF BIOSCIENCES, 2003, 28 (03) :249-264
[7]   A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and factor I cofactor function [J].
Blom, AM ;
Webb, J ;
Villoutreix, BO ;
Dahlbäck, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (27) :19237-19245
[8]  
Carroll M. C., 2004, HUMAN COMPLEMENT SYS, P327
[9]   The C4A and C4B isotypic forms of human complement fragment C4b have the same intrinsic affinity for complement receptor 1 (CR1/CD35) [J].
Clemenza, L ;
Isenman, DE .
JOURNAL OF IMMUNOLOGY, 2004, 172 (03) :1670-1680
[10]  
Cooper NR, 1998, HUMAN COMPLEMENT SYS, P393, DOI DOI 10.1201/B14212-19